- Filed
- May 15, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2026 · May 15, 2026 | 51.86M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2026 | 36.17M sh |
| Shares Diluted | Q1 2026 · Mar 31, 2025 | 29.72M sh |
| Capex | Q1 2026 · Mar 31, 2026 | $220.35K |
| Capex | Q1 2026 · Mar 31, 2025 | $2.83K |
| Operating Cash Flow | Q1 2026 · Mar 31, 2026 | −$2.93M |
| Operating Cash Flow | Q1 2026 · Mar 31, 2025 | −$546.67K |
| Short Term Investments | Q1 2026 · Mar 31, 2026 | $2.8M |
| Stockholders Equity | Q1 2026 · Mar 31, 2026 | $2.62M |
| Stockholders Equity | Q1 2026 · Dec 31, 2025 | $2.48M |
| Stockholders Equity | Q1 2026 · Mar 31, 2025 | $6.03M |
| Stockholders Equity | Q1 2026 · Dec 31, 2024 | −$983.18K |
| Current Liabilities | Q1 2026 · Mar 31, 2026 | $11.26M |
| Current Liabilities | Q1 2026 · Dec 31, 2025 | $6.73M |
| Total Liabilities | Q1 2026 · Mar 31, 2026 | $12.87M |
| Total Liabilities | Q1 2026 · Dec 31, 2025 | $8.46M |
| Current Assets | Q1 2026 · Mar 31, 2026 | $8.76M |
| Current Assets | Q1 2026 · Dec 31, 2025 | $2.31M |
| Total Assets | Q1 2026 · Mar 31, 2026 | $15.49M |
| Total Assets | Q1 2026 · Dec 31, 2025 | $10.93M |
| Eps Diluted | Q1 2026 · Mar 31, 2026 | −$0.18 |
| Eps Diluted | Q1 2026 · Mar 31, 2025 | −$0.07 |
| Eps Basic | Q1 2026 · Mar 31, 2026 | −$0.18 |
| Eps Basic | Q1 2026 · Mar 31, 2025 | −$0.07 |
| Sga Expense | Q1 2026 · Mar 31, 2026 | $4.21M |
| Sga Expense restated | Q1 2026 · Mar 31, 2025 | $1.89M |
| Rd Expense | Q1 2026 · Mar 31, 2026 | $357.07K |
| Rd Expense | Q1 2026 · Mar 31, 2025 | $91.26K |
| Net Income | Q1 2026 · Mar 31, 2026 | −$6.37M |
| Net Income | Q1 2026 · Mar 31, 2025 | −$1.98M |
| Revenue | Q1 2026 · Mar 31, 2026 | $14.93K |